LTGO · Latigo Biotherapeutics, Inc.
$23.04
+0.56 (+2.49%)
At close · Sep 4
Going-concern doubt
— cleared Sep 3, 2026
The latest filing states the doubt was alleviated.
“Accordingly, the prior substantial doubt about the Company's ability to continue as a going concern has been alleviated.”View the 10-Q filed Sep 3, 2026
Market Cap
$1.53B
Shares
66.30M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.